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Abstract
Background: Proteins of the ubiquitously expressed core proteome are quantitatively correlated across multiple
eukaryotic species. In addition, it was found that many protein paralogues exhibit expression anticorrelation,
suggesting that the total level of protein with a given functionality must be kept constant.
Methods: We performed Spearman’s rank correlation analyses of gene expression levels for the RAS GTPase subfamily
and their regulatory GEF and GAP proteins across tissues and across individuals for each tissue. A large set of published
data for normal tissues from a wide range of species, human cancer tissues and human cell lines was analysed.
Results: We show that although the multidomain regulatory proteins of Ras GTPases exhibit considerable tissue and
individual gene expression variability, their total amounts are balanced in normal tissues. In a given tissue, the sum of
activating (GEFs) and deactivating (GAPs) domains of Ras GTPases can vary considerably, but each person has balanced
GEF and GAP levels. This balance is impaired in cell lines and in cancer tissues for some individuals.
Conclusions: Our results are relevant for critical considerations of knock out experiments, where functionally related
homologs may compensate for the down regulation of a protein.
Keywords: Ras small GTPases, Tissue expression, Gene expression network, GTPase activating proteins, Guanine
nucleotide exchange factors
Background
The systematic profiling of gene and protein expression
levels in different tissues and cell types has enabled the
definition of common and unique components and the
functional characterisation of tissues and organs (‘What
makes a cell type?’) [1–4]. Expression and clustering
analysis revealed that core conserved genes and proteins
are expressed at similar levels in different eukaryotes [5]
and across various mammalian and non-mammalian
vertebrate tissues [6, 7]. However, it is unclear if there is
a quantitative expression association for groups of func-
tionally related genes and family members (homologs)
that do not belong to the evolutionary conserved ubiqui-
tous expressed core genes and proteins. Recently it has
been shown that functional divergence of paralogs is
fast, promoting tissue specificity [8]; in this, orthologues
show a high conservation in tissue-specificity, whilst
paralogs show less conservation [9]. We have shown
previously that paralogous gene pairs that are less simi-
lar in sequence homology and domain composition
showed expression anticorrelation profiles during the
calcium-induced differentiation of primary human
keratinocytes [10]. Anticorrelation of paralog gene expres-
sion was also observed in different brain regions [11]. This
suggests specialized time- and space-dependent roles of dif-
ferent paralogs and, more importantly, the need to keep the
same level of common functionalities carried out by
paralogs. We could ask if the same is true for antagonistic
activities regulating essential cell processes. An interesting
question is if the same could happen for antagonistic
activities regulating essential cell functions, such as those
mediated by the family of small GTPase proteins.
To answer this question about a family-wide expres-
sion balance, we choose the Ras p21 subfamily of small
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GTPases [12] (associated with cancer [13]), together with
their regulators, which direct diverse cellular processes by
cycling between GTP-bound active and GDP-bound
inactive conformations (Fig. 1a) [13, 14]. Cycling between
the ‘OFF states’ (GDP-bound) and the ‘ON-states’ (GTP-
bound) of Ras proteins is catalysed GTP exchange factors
domains (RasGEFs) and GTP activating domains
(RasGAP). The GEF and GAP regulators are multidomain
proteins of diverse composition (e.g. SH2, SH3, PH, RBD
domains) in addition to their catalytic GEF or GAP do-
mains (Additional file 1: Figure S1). Because each RAS sub-
family has GEFs and GAPs with unique catalytic domains
of 3D structural and sequence similarity, this makes them
in principle specific for each respective subfamily [15–17].
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Fig. 1 The Ras subfamily and their regulators, overview of analyses performed, and Spearman’s rank correlations. a Schematic diagram of the Ras
superfamily of small GTPases that cycle between a GDP-bound “OFF-state” and a GTP-bound “ON-state”. This cycling is regulated by GEF and GAP
proteins. b Number of Ras subfamily and regulators genes in four species (Homo sapiens, hs; Mus musculus, mm; dr, Danio rerio, dr; Drosophila
melanogaster, dm). c Schematic figure of protein and gene expression datasets used, and main data analyses performed in this study. d Spearman’s
rank correlation values of the ∑RAS vs ∑GEF, ∑RAS vs ∑GAP, and the ∑GEF vs ∑GAP displayed as a heat map (normal tissue datasets dmNT_01, ggNT_01,
oaNT, mdNT_01, mmNT_01, mmNT_02, mmuNT_01, ppyNT_01, ptNT_01, ppNT_01, ggoNT_01, hsNT_01, hsNT_02, hsNT_03, hsNT_04, hsNT_05).
e Heatmap representation of Spearman’s rank correlations of protein levels for GEFs with RASs, GAPs with RASs, and GEFs with GAPs across human
normal tissues. While correlations between the GEF with the RAS and the GAP with the RAS were generally poorer, higher correlations between the
GEF with the GAP were observed independently in both proteomic datasets. f Heatmap representation of Spearman’s rank correlations of protein and
RNA levels (hsNT_03). Parts of the pictures were drawn using Inkscape
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Here, we have analysed the gene and protein expres-
sion levels for the RAS GTPase subfamily and their
regulatory GEF and GAP proteins using a large set of
published data for normal tissues from a wide range of
species, human cancer tissues and human cell lines. We
show that the sum of all GEF family members (∑RAS-
GEF) generally correlates with the sum of all GAP family
members (∑RASGAP) in physiological normal tissues,
although the total sums for GEFs and GAPs could
change significantly between individuals. Thus, there is a
balance in gene and protein expression levels of RAS
regulators for normal tissues. These ∑RASGEF-∑RAS-
GAP correlations are lost or have a different slope in
transformed cell lines and in some individual cancer tis-
sues. This is caused by a higher sum of GAP levels in
cancer tissues of some individuals. Our work shows that
to understand the functionality of cell processes it is
important to consider all members of a protein family.
Individual proteins levels can be different from tissue to
tissue, but the sum of homologs is constant, possibly to
ensure adequate functional balance.
Methods
Transcriptomics data sources
We collected the following published datasets: (hsNT_01)
RNA-Seq gene expression dataset associated to H. sapiens
11 normal tissues [18] (hsNT_02) RNA-Seq gene expres-
sion dataset associated to H. sapiens 32 normal tissues
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB
-2836/); (hsNT_03) RNA-Seq gene expression dataset asso-
ciated to H. sapiens 53 normal tissues [19, 20] (GTEx);
(hsNT_04) RNA-Seq gene expression dataset associated to
H. sapiens 18 normal tissues (TCGA Research Network,
http://cancergenome.nih.gov/); (hsNT_05) RNA-Seq gene
expression dataset associated to H. sapiens 8 tissues [21];
(ggoNT_01) RNA-Seq gene expression dataset associated to
G. gorilla 6 tissues [21]; (ptNT_01) RNA-Seq gene expres-
sion dataset associated to P. troglodytes 6 tissues [21];
(ppNT_01) RNA-Seq gene expression dataset associated to
P. paniscus 6 tissues [21]; (ppyNT_01) RNA-Seq gene ex-
pression dataset associated to P. pygmaeus 5 tissues [21];
(mmulNT_01) RNA-Seq gene expression dataset associated
to M. mulatta 7 tissues [21]; (mmNT_01) RNA-Seq gene
expression dataset associated to M. musculus 6 tissues [21];
(mdNT_01) RNA-Seq gene expression dataset associated
to M. domestica 6 tissues [21]; (oaNT_01) RNA-Seq gene
expression dataset associated to O. anatinus 6 tissues [21];
(ggNT_01) RNA-Seq gene expression dataset associated to
G. gallus 6 tissues [21]; (mmNT_02) microarray gene
expression dataset associated to M. musculus 45 normal
tissues [22]; (dmNT_01) microarray gene expression data-
set associated to D. melanogaster 25 normal tissues [23];
(hsCT_01) RNA-Seq gene expression dataset associated to
H. sapiens 18 cancer tissues (TCGA Research Network
http://cancergenome.nih.gov/); (hsCT_02) microarray gene
expression dataset associated to H. sapiens 31 cancer tis-
sues [24] (COSMIC sanger cell line project); (hsCT_03)
microarray gene expression dataset associated to H. sapiens
163 cancer tissues (Expo database, http://www.intgen.org/
research-services/biobanking-experience/expo/); (hsCL_01)
RNA-Seq gene expression dataset associated to H. sapiens
56 cell lines (Human Protein Atlas, http://www.ncbi.nlm.-
nih.gov/bioproject/PRJNA183192); (hsCTL_02) microarray
gene expression dataset associated to H. sapiens cell lines
from 24 cancer tissues (Cancer Cell Line Encyclopedia
[25]). RPKM (Reads Per Kilobase per Million mapped
reads) or TPM (Transcripts Per Kilobase Million) values
were used for RNA-Seq data, while total RNA levels from
microarray datasets were utilized. We have always consid-
ered the most expressed isoform for each gene.
Proteomics data sources
The PaxDB, a mass spectrometry-based proteomic
meta-resource across organisms was used to extract pro-
tein information [26]. The average spectral counting
value derived from all experiments (in different cell lines
and tissues) corresponds to an approximate protein
abundance estimate for the respective organism (ppm
values for ‘whole organisms’ and integrated tissues’ in
PaxDb). To retrieve protein levels for RAS, GEF, and
GAP members in different organisms and under differ-
ent conditions (e.g. cell lines, normal tissues), we first
analyzed the PaxDB (Additional file 2). We found a good
coverage of expression information using the ‘whole or-
ganism’ expression score, which is an average spectral
counting value derived from all mass spectrometry ex-
periments from different cell lines and tissues. Similarly,
we retrieved integrated expression information for 20
tissues from the PaxDB and for 20 tissues from a recent
deep proteomic study [3]. However, the complete
quantification of lower abundance proteins and of iso-
forms and family members (that often contain only a
few unique or no unique tryptic peptides) by mass spec-
trometry in tissues is not feasible [27].
Selection of Ras, RasGEF, and RasGAP family members
Members of the Ras family were selected based on the
presence of a predicted Ras domain using either the
SMART (accession number: SM00173; http://smar-
t.embl-heidelberg.de/) or the Pfam database (accession
number: PF00071; https://pfam.xfam.org/) (Table 1,
Table 2, Additional file 3). All 36 Ras family members
were also present in a detailed bioinformatics evolution-
ary tree analysis of the whole RAS superfamily [12].
Members of the RasGEF family were selected based on
the presence of a predicted Ras domain using either the
SMART (accession number: SM00147; http://smar-
t.embl-heidelberg.de/) or the Pfam database (accession
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number: PF00617; https://pfam.xfam.org/). Members of
the RasGAP/[RapGAP] family were selected based on
the presence of a predicted RasGAP domain using either
the SMART (accession number: SM00323; http://smar-
t.embl-heidelberg.de/) or the Pfam database (accession
numbers RasGAP: PF00616 and RapGAP: PF02145;
https://pfam.xfam.org/). NF2 was excluded from the list
of RasGAPs as despite its name, NF2 is not related to
NF1 and does not display GAP activity against any Ras
GTPase [15].
Gene expression values and sums
The data sets labeled as mmNT_02, dmNT_01, hsCT_02,
hsCT_03, and hsCL_02 are based on microarray measure-
ments. For these data sets, total RNA levels were utilized.
The remaining data sets are based on RNA sequencing
technology. The RPKM (hsNT_01, hsNT_03, hsNT_04,
hsNT_05, ggoNT_01, ptNT_01, ppNT_01, ppyNT_01,
mmulNT_01, mmNT_01, mdNT_01, oaNT_01, ggNT_01,
hsCT_01) or TPM (hsNT_02, hsCL_01) values (the way as
presented by the original studies/databases) were utilized
without applying any normalization or scaling factor. The
sums for RAS, GEF, and GAP genes were computed by
summing the original data for each corresponding gene. If
there was more than one splice variant for a gene, the
maximum expression variant was used. There are some
genes missing in some of the data sets (especially in
microarray-based sets). The missing gene expression level
was assumed to be zero.
Correlations
The gene expressions (array-based, RPKM or TPM) were
used to determine the sum of GEF and GAP members, in
different tissues/cell models with the Spearman’s rank cor-
relation metric. Random correlations were determined
based on independent shuffling of the expression levels of
Ras family genes. The procedure was repeated 10,000
times, for each dataset. Finally, the real correlation value
was compared to the distribution of shuffled correlations.
The hypothesis that the real correlation value is signifi-
cantly different than the random correlation distribution
was tested via p-value, based on z-scores. To check that
the high correlations were not dominated by one highly
expressed family member, each GEF and GAP was re-
moved one by one and the correlation was re-calculated
(‘bootstrapping’). The effect of gene removal on GEF to
GAP correlation values was not significant for either
the normal tissue or the cancer tissue datasets. The signifi-
cance of the difference between the matching normal and
cancer dataset correlation values was determined by Fish-
er’s test; the correlation values were transformed to
z-scores by using the sample size (number of individuals).
Ratios
The gene expression levels from TCGA data set were
used to determine the sum of GEF and GAP members,
for the matching normal and cancer tissues.
Mann-Whitney U test was applied to determine if the
normal tissue ratios were significantly different from
those of cancer tissues.
Table 1 Selection of Ras superfamily members. Selection of
family members based on domain predictions using the SMART
or Pfam databases, or based on Rojas et al., 2012
Gene name RAS domain
in SMART
RAS domain
in Pfam
Rojas et al. 2012
Ras family DIRAS1 YES YES YES
DIRAS2 YES YES YES
DIRAS3 NO YES YES
ERAS YES YES YES
GEM NO YES YES
HRAS YES YES YES
KRAS YES YES YES
MRAS YES YES YES
NKIRAS1 NO YES YES
NKIRAS2 NO YES YES
NRAS YES YES YES
RALA YES YES YES
RALB YES YES YES
RAP1A YES YES YES
RAP1B YES YES YES
RAP2A YES YES YES
RAP2B YES YES YES
RAP2C YES YES YES
RASD1 YES YES YES
RASD2 YES YES YES
RASL10A NO YES YES
RASL10B NO YES YES
RASL11A NO YES YES
RASL11B NO YES YES
RASL12 NO YES YES
REM1 NO YES YES
REM2 NO YES YES
RERG YES YES YES
RERGL NO YES YES
RHEB YES NO YES
RHEBL1 YES NO YES
RIT1 YES NO YES
RIT2 YES NO YES
RRAD NO YES YES
RRAS YES YES YES
RRAS2 YES YES YES
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Slope test
The gene expression values (array-based, RPKM, or
TPM) were used to determine the sum of GEF and GAP
members’ expression, for the matching normal and can-
cer tissues/ cell models. A non-parametric t-test (based
on the regression line fitted to GEF GAP sums, the
standard error of regression, the standard deviation of
∑GEF ∑GAP, and the number of individuals) was used
to determine the significant changes between the slopes
of the matching normal and cancer samples.
bn: slope of the fitted line for normal tissue.
bc: slope of the fitted line for cancer tissue.
Syxn: standard error of the fitted line for normal tissue.
Syxc: standard error of the fitted line for cancer tissue
Sxn: standard deviation of the sum of GEF values in normal
tissue.
Sxc: standard deviation of the sum of GEF values in
cancer tissue
Sbn ¼ Syxn
Sxn tn−1ð Þ2
Sbc ¼ Syxc
Sxc tc−1ð Þ2
where tn and tc are the number of individuals (data points)
in normal and cancer tissue data sets, respectively.
S ¼ Sbn−Sbc
T ¼ bn−bcð Þ=S
DF ¼ tn−tc−4
The corresponding p-value for the change in the
slopes for normal versus cancer tissue is determined via
t-test using the T and DF (degrees of freedom) values.
Survival test
The TCGA data set was employed to determine the sur-
vival rates of patients with respect to their ∑RasGAP/
∑RasGEF ratios. The “TCGA2STAT” R library was
employed to download the matching RNA-Seq (RPKM)
and clinical data sets. The clinical data were utilized to
Table 2 Selection of Ras superfamily member RasGEF and
RasGAP regulators. Selection of family members based on
domain predictions using the SMART or Pfam databases
Gene name RAS domain
in SMART
RAS domain
in Pfam
RasGEF family KNDC1 YES YES
PLCE1 YES YES
RALGDS YES YES
RALGPS1 YES YES
RALGPS2 YES YES
RAPGEF1 YES YES
RAPGEF2 YES YES
RAPGEF3 YES YES
RAPGEF4 YES YES
RAPGEF5 YES YES
RAPGEF6 YES YES
RAPGEFL1 YES YES
RASGEF1A YES YES
RASGEF1B YES YES
RASGEF1C YES YES
RASGRF1 YES YES
RASGRF2 YES YES
RASGRP1 YES YES
RASGRP2 YES YES
RASGRP3 YES YES
RASGRP4 YES YES
RGL1 YES YES
RGL2 YES YES
RGL3 YES YES
RGL4 YES YES
SOS1 YES YES
SOS2 YES YES
RasGAP family DAB2IP YES YES
GARNL3 NO YES
NF1 YES YES
PLXNB1 NO YES
RALGAPA1 NO YES
RALGAPA2 NO YES
RAP1GAP NO YES
RAP1GAP2 NO YES
RASA1 YES YES
RASA2 NO YES
RASA3 NO YES
RASA4 NO YES
RASAL1 NO YES
RASAL2 YES YES
RASAL3 YES YES
Table 2 Selection of Ras superfamily member RasGEF and
RasGAP regulators. Selection of family members based on
domain predictions using the SMART or Pfam databases
(Continued)
Gene name RAS domain
in SMART
RAS domain
in Pfam
SIPA1 NO YES
SIPA1L1 NO YES
SIPA1L2 NO YES
SIPA1L3 NO YES
SYNGAP1 YES YES
TSC2 NO YES
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derive the “survival time” and “death/alive status” for each
patient. The gene expression values were used to determine
the sum of GEF and GAP members, and the corresponding
ratio for each patient. For each cancer tissue, the corre-
sponding normal tissue data set (TCGA) was used to
determine ratio thresholds; “mean of normal ratio + 2 times
standard deviation of normal ratio”. These tissue-specific
ratio thresholds were used to stratify each patient as having
a high- or a low-ratio. A survival function was fitted on the
stratified data (based on high- or low-ratio), survival time,
and death/alive status. The Kaplan-Meier plots for these
fitted survival functions were depicted. The significance of
difference between high- and low-ratio values are indicated
on plots, with a p-value. The “survminer” R library was
used for the survival analysis.
Results
Correlation of ∑RAS, ∑RASGEF and ∑RASGAP levels in
adult normal tissues
We included in our study all RAS members and their GEF
and GAP regulator members from human (Homo sapi-
ens), other primates (Gorilla gorilla, Macaca mulatta, Pan
paniscus, Pan troglodytes, and Pongo pygmaeus), other
mammals (Mus musculus, Monodelphis domestica, and
Ornithorhynchus anatinus), bird (Gallus gallus), fish
(Danio rerio), and fly (Drosophila melanogaster), we used
Pfam domain predictions and additional manual annota-
tions based on recent reviews (Additional file 3) [12, 15].
We used public repositories and selected publications
to retrieve gene expression data required for the subse-
quent workflow of performing correlations and ratios of
RAS/ RASGEF/ RASGAP sums (Fig. 1c). The gene ex-
pression levels for RAS, RASGEF, and RASGAP mem-
bers under different conditions (normal tissues and
organs from various species, human cancer tissues,
human cell lines) were retrieved and quantitative RNA
Seq datasets were prioritised [28] (see Methods and
Additional file 1: Figure S2). We analysed the gene ex-
pression correlations of the sums of RAS and regulators in
adult fly (dmNT_01), chicken (ggNT_01), platypus
(oaNT), opossum (mdNT_01), mouse (mmNT_01,
mmNT_02), primates (mmuNT_01, ppyNT_01, ptNT_01,
ppNT_01, ggoNT_01), and human (hsNT_01, hsNT_02,
hsNT_03, hsNT_04, hsNT_05) tissues (see Additional file 4).
We found good correlations between the ∑GEF with the
∑GAP (Fig. 1d; Additional file 1: Figure S3A). Correlations
between the ∑GEF with the ∑RAS and the ∑GAP with the
∑RAS were generally poorer (Fig. 1d). While a strong and
significant (p-value < 0.05) correlation between the GEFs
and the GAPs across tissues was found, the individual
GEFs and GAPs showed a large distribution of correlation
values (Additional file 1: Figure S3B), without any bias of
higher correlations being associated to higher expression
values (Additional file 1: Figure S3C). Thus, while the gene
expression levels of individual GEF and GAP family mem-
bers may vary in a given tissue, the sum of all GEFs and
GAPs for a RAS subfamily is correlated.
To measure the significance of the correlation values,
the RAS, GEF, and GAP gene expression values were
shuffled 10,000 times and the correlation between the
ƩGEFs and the ƩGAPs was determined (Additional file 5).
We observed a strong correlation for the ƩGEF and the
ƩGAP levels across normal adult tissues in most data in
comparison to the shuffled background (p-value < 0.05)
(Additional file 1: Figure S4). Focusing on a subset of ex-
perimentally validated GEFs and GAPs (RASGEF1A,
RASGRP1, RASGRP4, SOS1, RASGRP2, NF1, RASA1, and
RASA4) identified significant, but lower correlations values
in all five human normal datasets (Additional file 5).
We also confirmed the GEF to GAP gene expression
correlation across normal tissues at the protein level using
the spectral counting score of the mass spectrometry-based
proteomic meta-resource PaxDB [26]. The whole organism
∑RAS, ∑RASGEF and ∑RASGAP protein levels for human,
mouse, worm, and fruit fly indicated no correlation
between ∑RAS versus ∑RASGEF and also not between
∑RAS and ∑RASGAP. However, similar to the gene expres-
sion analysis, reasonable ∑RASGEF versus ∑RASGAP
correlation values were observed for three organisms, but
not for worm (Additional file 2). We further analysed the
protein expression levels across human tissues (PaxDB [26]
and Kim et al. [3]), where generally good correlation values
between ∑RASGEF versus ∑RASGAP were found (Fig. 1e;
Additional file 2). The correlation values of ∑RASGEF ver-
sus ∑RASGAP for protein and gene expression levels were
in good agreement (Fig. 1f) even though not perfect – due
to the low abundance of proteins. In conclusion, the overall
correlation of ∑RASGEF and ∑RASGAP protein/gene
levels in normal tissues indicates a balance of these entities.
Correlation of ∑RAS, ∑RASGEF and ∑RASGAP levels in
adult normal tissues across individuals
As the gene expression values from the human normal tis-
sues from the GTEx consortium were average values of
several individuals for each tissue (dataset hsNT_03), we
next analysed whether or not the expression balance was
even stronger in the same tissues of different individuals.
In the small intestine tissue, for example, the ∑GEF and
∑GAP levels spanned a large expression range from 100
to 500 RPKM in different individuals, but the ∑GEF and
∑GAP levels were balanced in the same person (Fig. 2a).
In other tissues that had a smaller dynamic range of ex-
pression (e.g. colon) we still found a significant correlation
(Fig. 2b). We observed this expression balance throughout
all/most tissues (Fig. 2c, Additional file 1: Figure S5, and
Additional file 6). As observed before using the averaged
tissue expression datasets, the correlation between RAS
members and their GEFs or GAPs was generally lower
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(Additional file 6). In summary, the expression levels of
GEF and GAP family members may vary in different indi-
viduals for a particular tissue, but the sum of all GEFs and
GAPs was found to correlate in the same person.
Gene expression ratios of RAS and regulators in normal
adult tissues
To obtain insights into the quantitative relation among
RAS and regulators, we compared the ratios of the ∑RAS,
∑GEF, and ∑GAP levels across the human normal tissues.
We observed that the ratios for a given tissue were quite
comparable in various datasets (Additional file 7;
Additional file 1: Figure S6). We found that the average
∑GEF/∑GAP ratio across all tissues was 1.12, but ratios
could be as low as 0.69 and as high as 2.57, suggesting that
the ratio is constant in a particular tissue (Fig. 3). How-
ever, we could not identify a correlation between the ratio
and tissue turnover times as a measure of tissue prolifera-
tion [29], suggesting that the ∑GEF/∑GAP ratio in individ-
ual tissues is unrelated to proliferation (Additional file 7).
a
c
b
Fig. 2 Spearman’s rank correlations in different tissues across individuals. a Correlation of the ∑GEF with the ∑GAP in small intestine across 88 individuals
(GTEx, hsNT_03). b Correlation of the ∑GEF with the ∑GAP in colon across 149 individuals (GTEx, hsNT_03). c Heatmap of Spearman’rank correlation values
across individuals for all tissue analysed. The part of the picture that represents a scheme of a human being was drawn using Inkscape
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Loss of GEF and GAP expression correlation in human
cancer tissues and cell lines
Correlation and clustering signatures previously revealed
that various cancer types share a common gene expres-
sion profile, which differs from normal tissues and
suggesting an underlying ‘near universal’ cellular dys-
function that is associated with cancer [30, 31]. Thus, we
analysed the correlations between the ƩGEFs and ƩGAPs
using cancer tissue expression datasets (datasets
hsCT_01, hsCT_02, and hsCT_03) and cell lines (dataset
hsCL_01 and hsCL_02) (Additional file 8). We found
that the correlation value was often lower or lost in
cancer tissues and cell lines (Additional file 1: Figure S7).
Moreover, the correlation values for the cancer datasets
were often not significantly different from the randomized
data (Additional file 9). This suggests that some cancer
tissues and cell lines do not have balanced ∑GEF and
∑GAP levels.
To obtain further insights into the loss of correlation,
we next analysed correlations across individuals in differ-
ent cancer tissues (from the TCGA database). The TCGA
data contain corresponding ‘normal’ tissue data that were
taken from the same tissue, but from areas further away
from the tumour (datasets hsCT_01 and hsNT_04). As
the number of samples with from those ‘normal’ individ-
ual tissues were generally lower, we also analysed the nor-
mal tissues from individuals from the GTEx database
(hsNT_03). The normal tissues from TCGA (hsNT_04)
and GTEx (hsNT_03) generally agreed well when compar-
ing the same tissue (Additional file 1: Figure S8;
Additional file 10). For each tissue we performed correla-
tions across individuals by treating the merged normal
tissue data (hsNT_03 and hsNT_04) and cancer tissue
data separately (Fig. 4; Additional file 1: Figure S8). Simi-
larly to the overall correlations across cancer tissues, we
observed that generally the correlations for specific cancer
tissues were lower compared to normal tissues (Fig. 4;
Additional file 1: Figure S8; Additional file 11) (16% of
matching data and 23% of merged data had a significant
change in correlation, p-value < 0.05). More importantly,
however, we found that the slopes of ∑RASGEF-∑RAS-
GAP were in five cases (bladder, liver, ovary, prostate,
stomach) significantly increased, p-value 0.05 (Fig. 4;
Additional file 1: Figure S8; Additional file 11). The in-
creased slopes were due to increased ∑RASGAP levels in
some tumours. However, there was a large heterogeneity
in the tumours and only a fraction of tumours had higher
∑RASGAP levels. While there was no relation observed
between the ∑GAP/∑GEF ratios and tumour stages
(Additional file 12), for some cancer tissues (lung, cervix,
and liver), a significant decrease in patient survival was
observed for higher ∑GAP/∑GEF ratios suggesting that
this ratio may be used as a prognostic indicator for sur-
vival (Additional file 1: Figure S9).
Taken together, these data suggest that the expression
levels of small Ras-like GTPase regulators must be
balanced to achieve the normal physiological function-
ing. The dysregulation of ∑GEF, ∑GAP and ∑RAS levels
suggest that this may serve an additional hallmark of
some cancers.
Discussion
Here we show that sum of gene expression levels of GEF
and GAP regulators of RAS GTPases is balanced in
physiologically normal cell types and tissues. Genetic
buffering and compensation has been shown to involve
paralogs of genes that contain both functional overlap and
functional differences [32]. The functional overlap for the
families of GEFs or GAPs is given by their catalytic
domains with GEF or GAP activity towards RAS small
Fig. 3 Ratios for the sum of RasGEF and RasGAP regulators in normal tissues. a Analysis of ∑RasGEF/∑RasGAP ratios in different human normal
tissues (datasets hsNT_01, hsNT_02, hsNT_03, hsNT_04, and hsNT05). Similar tissues from different datasets were averaged (see Additional file 7)
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GTPases. The functional differences can be achieved using
their multidomain nature containing a wide-range of dif-
ferent domains, which can affect their localization or spe-
cific functionalities such as the formation of complexes
with other cellular proteins. Thus, individual activating
(GEFs) and deactivating domains (GAPs) could change
significantly their expression to perform particular func-
tions using their other domains in particular tissues, but
the overall balance for the GEF and GAP functionality is
kept. The balanced expression of GEFs and GAPs should
in principle enable a constant RAS activity (GTP vs GDP
bound forms) in the normal tissues under constant growth
signals, although protein levels do not necessarily relate
1:1 to protein activities. The finding that a subset of genes
correlates weaker than the complete set but stronger than
the random set is not unexpected. It is possible that, in fu-
ture work, the identification of other subsets that correlate
and characterizing their functions experimentally will fur-
ther our understanding of the mechanisms of control of
GEF/GAP expression and their role in the Ras pathway.
We also show that the GEF-GAP expression correl-
ation is lost in some individual tumour tissues and cell
lines. GEFs and GAPs have been frequently found to be
differentially expressed in cancer [15, 33, 34]. Correl-
ation and clustering signatures previously revealed that
various cancer types share a common gene expression
profile, which differs from normal tissues and suggests
an underlying ‘near universal’ cellular dysfunction that
results in cancer [30, 31]. Our work suggests that imbal-
ances of GEF and GAP family members could be one
Fig. 4 Correlations of the sum of RasGEF and RasGAP across individuals in different tissues. Spearman’s rank correlation of the ∑RasGEF with the
∑RasGAP in different normal (red squares) and cancer (blue squares) tissues across individuals (datasets hsNT_03 and hsCT_01). The correlation
values (C) and slopes (S) are indicated in the figure. Significantly different changes in slopes or correlations comparing normal and cancer tissues
are indicated next to the tissue name (plot titles), with orange and purple stars (*), respectively
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feature of this dysregulation in some cancers. However,
in is unclear if it is a cause or consequence of cancer
development.
The fundamental mechanistic question of how levels
of GEF and GAP are regulated and why they are altered
in cancer tissues warrants further investigation. It is
expected that the dosage of genes belonging to a func-
tional group are under the control of signal transduction
pathways and transcription factors [35]. For example, it
has been shown that polo-like kinase 2 coordinates
multiple GAPs and GEFs for synchronised tuning and
activation of Ras and Rap small GTPases important for
synaptic plasticity [36]. The most likely explanation
being that the RAS activity state and downstream signal-
ling itself induces positive and negative feedback mecha-
nisms that control GEF and GAP levels through
transcriptional regulation. Therein, a likely hypothesis is
that levels are regulated by both GEF- and GAP-specific
transcription factors and general transcription factors in-
duced downstream of RAS.
It is quite remarkable that there are large differences
in the sum of GEF and sum of GAP levels in the same
tissue for different individuals, while in each individual a
near perfect balance of sum of GEFs and GAPs is found.
These individual expression differences are important to
be considered in personalised medicine approaches,
where for example a marker GEF protein that is highly
expressed might be indicative of a bad prognosis in some
individuals. However, in those individuals that have in
general lower GEF and GAP levels this marker GEF pro-
tein might be missed if one compares to the average
population expression levels.
Taken together, our data suggest that the expression
levels of regulators of RAS GTPases must be balanced to
achieve the normal physiological function in adult tis-
sues. It is quite likely that similar phenomena are found
in other multidomain groups of proteins sharing a func-
tional domain. Thus, the finding that the protein paralo-
gue expression levels quite often anticorrelate to keep
constant a certain common functionality must now be
extended to proteins sharing a common functional do-
main like GEFs and GAPs. For example, we have shown
in mouse small intestine that knocking out the RhoGEF
Tiam1 or Vav3 causes the upregulation of another Rho-
GEF, Vav2 (Pickering et al., manuscript under revision in
Nature Communications). Only by knocking out all the
three RhoGEFs simultaneously is suppression of the
APCfl/fl hyperproliferative phenotype observed.
Conclusions
Our study shown that the function of multidomain pro-
teins cannot be understood without considering all family
homologs and explains why in many cases homologs ex-
hibit expression anticorrelation. We suggest that future
experimental analyses should include systemic changes of
all protein family members rather than focusing on one
particular protein. Further, our results are relevant for
critical considerations of knock out experiments, where
functionally related homologs may compensate for the
down regulation of a protein.
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